PROJECTS

SAFEnmt H2020

Open Innovation Test Bed Program

Helia Biomonitoring is a partner in the SAFEnmt H2020 Open Innovation Test Bed Program, which is funded by the European Union’s Horizon 2020 Research and Innovation Program. 

 

The pilot test case proposes the continuous and automatic monitoring of biomolecules for optimal patient care, based on biosensing by particle mobility.